Human Tonik LLC – Trademark Portfolio

Entity Type: 16

Human Tonik LLC holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include RED TONIK, HUMAN TONIK, and SUPERGREEN TONIK. The owner is based in CLAYMONT, DE.

2093 PHILADELPHIA PIKE #2888

CLAYMONT, DE 19703

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Human Tonik LLC's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Human Tonik LLC have?

Human Tonik LLC has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 abandoned.

What trademark classes does Human Tonik LLC file in?

Human Tonik LLC files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Human Tonik LLC's most well-known trademarks?

Human Tonik LLC's registered trademark portfolio includes well-known marks such as RED TONIK, HUMAN TONIK, and SUPERGREEN TONIK. These are among 3 currently registered trademarks in the portfolio.

What is Human Tonik LLC's trademark registration success rate?

Human Tonik LLC has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.